Please assess the completion status of the following clinical trial:

Trial Title: Radiotherapy for Malignant Astrocytomas in the Elderly

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed~* Brain CT scan or MRI within 28 days before surgery~* Age: 70 years or older~* Karnofsky performance status, 70 or more.~* Life expectancy over 12 weeks~* Informed consent~Exclusion Criteria:~* Brain radiotherapy~* Chemotherapy~* Severe systemic disease

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).